Setting a research agenda for examining early risk for elevated cognitive disengagement syndrome symptoms using data from the ABCD cohort

Kelsey K. Wiggs, Taryn E. Cook, Isha Lodhawala, Emma N. Cleary, Kimberly Yolton, Stephen Becker

TL;DR

This study investigates early life risk factors associated with Cognitive Disengagement Syndrome (CDS) symptoms in children aged 9-10, using a large dataset from the ABCD study. The findings highlight several prenatal and perinatal factors that significantly increase the odds of elevated CDS symptoms, suggesting a need for further research into these early origins to inform prevention and intervention strategies.

What Problem Does This Paper Address?

Cognitive Disengagement Syndrome (CDS), previously known as sluggish cognitive tempo (SCT), is characterized by internally-focused distraction, mental confusion, and hypo-activity. While CDS frequently co-occurs with Attention-Deficit/Hyperactivity Disorder (ADHD), its specific early life origins are not well understood. Existing research on prenatal risk factors for CDS is limited and has yielded mixed results, often due to small sample sizes. This paper aims to address this gap by examining a broad range of early life risk factors (prenatal, perinatal, and developmental milestones) and their associations with elevated CDS symptoms in a large, representative sample of U.S. children, thereby setting a research agenda for future investigations.

Methods

The study employed secondary analyses of baseline data from the Adolescent Brain Cognitive Development (ABCD) study. This involved a large cohort of children aged 9-10 years old. Birthing parents reported on various early life risk factors through a developmental history questionnaire, covering parental, prenatal, delivery, and birth information, as well as developmental milestones. The Child Behavior Checklist (CBCL) was used to assess CDS symptoms, with elevated symptoms defined by a T-score of 70 or higher. The researchers calculated odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the magnitude of bivariate associations between these early life exposures and elevated CDS symptoms. The analyses were exploratory, including only participants with complete data for the variables of interest.

Datasets

The primary dataset used in this study is the Adolescent Brain Cognitive Development (ABCD) Study. This is a prospective, longitudinal study of U.S. children, with baseline data collected from 2017 to 2018. The specific data release used was Release 4.0. The study involved a final sample of 8,096 children after exclusions for prematurity, missing questionnaires, and other data quality issues. No new benchmarks were introduced; the study utilized existing data and established measures.

Key Insights and Ideas

  • Early life matters: The study strongly suggests that a child's early life experiences, even before birth, can significantly influence the likelihood of developing symptoms of Cognitive Disengagement Syndrome.
  • Beyond genetics: While genetics likely play a role, this research highlights the substantial impact of environmental and situational factors during pregnancy and birth.
  • A call for focus: The findings pinpoint specific areas (e.g., prenatal substance exposure, certain pregnancy complications, and delayed developmental milestones) that warrant prioritized research attention for understanding CDS.
  • Complex interplay: The results hint at the complex interplay between various risk factors, suggesting that some factors might act as proxies for broader issues like lack of prenatal care or exposure to teratogens.

Key Results

The study identified several significant associations between early life risk factors and elevated CDS symptoms:

  • Parental Risk Factors: Unplanned pregnancies (OR = 1.60), pregnancy awareness after 6 weeks (OR = 1.47), and teenage parenthood (OR = 1.93 for birthing parent, OR = 1.90 for other parent) were associated with higher odds of elevated CDS.
  • Birthing Parent Illness: Persistent proteinuria (OR = 9.53), preeclampsia/toxemia (OR = 2.02), severe nausea (OR = 2.28), severe anemia (OR = 2.48), and urinary tract infection (UTI) (OR = 2.51) were significantly associated with increased odds of CDS.
  • Pregnancy Complications: Heavy bleeding during pregnancy showed a significant association (OR = 2.60).
  • Prenatal Substance Exposure: Illicit drug use (OR = 2.89), tobacco exposure (OR = 1.90), and prescription medication use (OR = 1.62) were linked to higher odds of CDS. Alcohol use was not statistically significant.
  • Delivery and Birth: Being blue at birth (OR = 2.57) and not breathing at first (OR = 2.10) were strongly associated with elevated CDS. Jaundice requiring treatment (OR = 1.88) and incubation after delivery (OR = 1.68) also showed significant associations. Prematurity, low birth weight, and C-section delivery did not show significant associations in this sample.
  • Developmental Milestones: Late motor development (OR = 2.61) and late speech development (OR = 2.56) were significantly associated with higher odds of elevated CDS.

Limitations and Future Work

The authors acknowledge several limitations:

  • Causality: The study design is cross-sectional, preventing the determination of causality. Associations observed are bivariate and do not account for potential confounding factors.
  • Sample Exclusions: The exclusion of extremely premature infants limits the generalizability of findings related to prematurity and low birth weight. The lower prevalence of clinically elevated CDS symptoms in the ABCD cohort compared to some prior studies might indicate that the sample does not fully capture a subset of at-risk children.
  • Recall Bias: While efforts were made to mitigate recall bias, parental reporting of exposures can be subject to inaccuracies.
  • Measure Specificity: Some composite variables (e.g., for illicit drugs or prescription medications) may mask specific drug effects.

Future research directions suggested include:

  • Causal Inference: Employing more rigorous designs like covariate adjustment, quasi-experimental designs (e.g., sibling comparisons), and active comparator matching to explore causal relationships.
  • Comprehensive Measures: Utilizing more comprehensive CDS measures, similar to those used in prior studies, to better detect associations.
  • Common and Unique Risk Factors: Investigating shared and distinct risk factors for CDS and co-occurring difficulties like ADHD and autism spectrum disorder.
  • Specific Exposures: Further research is needed to specify which illicit drugs and prescription medications are most strongly associated with CDS.
  • Replication with Premature Infants: Conducting studies with samples that include extremely premature infants to better understand the role of prematurity and fetal growth restriction.
  • Developmental Milestones as Markers: Investigating whether late motor and speech development are true markers for CDS or if their association is explained by co-occurrence with ADHD.

Summary updated

Abstract

Several early-life risk factors were associated with elevated odds of CDS at ages 9-10 years; study design prevents the determination of causality. Further investigation is warranted regarding early life origins of CDS with priority given to risk indices that have upstream commonalities (i.e., that restrict fetal growth, nutrients, and oxygen).
BibTeX
@inproceedings{wiggs2025setting,
  author = {Kelsey K. Wiggs and Taryn E. Cook and Isha Lodhawala and Emma N. Cleary and Kimberly Yolton and Stephen Becker},
  title = {{Setting a research agenda for examining early risk for elevated cognitive disengagement syndrome symptoms using data from the ABCD cohort}},
  booktitle = {European},
  year = {2025},
  doi = {10.1007/s00787-025-02667-z},
}
Figure